{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:06:38Z","timestamp":1788185198875,"version":"build-2803163510"},"reference-count":122,"publisher":"Sociedade Brasileira de Cardiologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,7]]},"DOI":"10.36660\/abc.20200702","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T14:57:25Z","timestamp":1633705045000},"page":"750-764","source":"Crossref","is-referenced-by-count":22,"title":["Atualiza\u00e7\u00e3o no Tratamento da Hipertens\u00e3o Arterial Pulmonar"],"prefix":"10.36660","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-021X","authenticated-orcid":false,"given":"Caio J.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-8999","authenticated-orcid":false,"given":"Daniela","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Luppino","family":"Assad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Salibe-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Tamie","family":"Kato-Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Hoette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Piloto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-3937","authenticated-orcid":false,"given":"Marcela Ara\u00fajo","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Pontes","family":"Lisboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taysa Antonia Felix da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murillo de Ara\u00fajo","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Alves-Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Terra-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","reference":[{"issue":"115","key":"key20211008092743_B1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09059180.00007309","article-title":"Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Pathophysiology","volume":"19","author":"Humbert","year":"2010","unstructured":"1. Humbert M. Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Pathophysiology. Eur Respir Rev. 2010;19(115):59-63. doi: 10.1183\/09059180.00007309.","journal-title":"Eur Respir Rev"},{"issue":"5","key":"key20211008092743_B2","article-title":"Pulmonary Hypertension: Definition, Classification, and Diagnosis","volume":"38","author":"Alves","year":"2017","unstructured":"2. Alves JL Jr, Oleas FG, Souza R. Pulmonary Hypertension: Definition, Classification, and Diagnosis. Semin Respir Crit Care Med. 2017;38(5):561570. doi: 10.1055\/s-0037-1606577.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"key20211008092743_B3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global View of Pulmonary Hypertension","volume":"4","author":"Hoeper","year":"2016","unstructured":"3. Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global View of Pulmonary Hypertension. Lancet Respir Med. 2016;4(4):306-22. doi: 10.1016\/S2213-2600(15)00543-3.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"key20211008092743_B4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in Patients with Primary Pulmonary Hypertension. Results from a National Prospective Registry","volume":"115","author":"D\u2019Alonzo","year":"1991","unstructured":"4. D\u2019Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in Patients with Primary Pulmonary Hypertension. Results from a National Prospective Registry. Ann Intern Med. 1991;115(5):343-9. doi: 10.7326\/0003-4819-115-5-343.","journal-title":"Ann Intern Med"},{"issue":"5","key":"key20211008092743_B5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCP.0000000000000086","article-title":"Goal-Oriented Treatment of Pulmonary Arterial Hypertension","volume":"20","author":"Jardim","year":"2014","unstructured":"5. Jardim C, Fernandes CJ, Souza R. Goal-Oriented Treatment of Pulmonary Arterial Hypertension. Curr Opin Pulm Med. 2014;20(5):409-13. doi: 10.1097\/MCP.0000000000000086.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"key20211008092743_B6","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-014-0130-3","article-title":"Quality of Life as a Prognostic Marker in Pulmonary Arterial Hypertension","volume":"12","author":"Fernandes","year":"2014","unstructured":"6. Fernandes CJ, Martins BC, Jardim CV, Ciconelli RM, Morinaga LK, Breda AP, et al. Quality of Life as a Prognostic Marker in Pulmonary Arterial Hypertension. Health Qual Life Outcomes. 2014;12(1):130. doi: 10.1186\/s12955-014-0130-3.","journal-title":"Health Qual Life Outcomes"},{"issue":"125","key":"key20211008092743_B7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1183\/09059180.00003512","article-title":"A Critical Analysis of Survival in Pulmonary Arterial Hypertension","volume":"21","author":"O\u2019Callaghan","year":"2012","unstructured":"7. O\u2019Callaghan DS, Humbert M. A Critical Analysis of Survival in Pulmonary Arterial Hypertension. Eur Respir Rev. 2012;21(125):218-22. doi: 10.1183\/09059180.00003512.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"key20211008092743_B8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic Definitions and Updated Clinical Classification of Pulmonary Hypertension","volume":"53","author":"Simonneau","year":"2019","unstructured":"8. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic Definitions and Updated Clinical Classification of Pulmonary Hypertension. Eur Respir J. 2019;53(1):1801913. doi: 10.1183\/13993003.01913-2018.","journal-title":"Eur Respir J"},{"issue":"4","key":"key20211008092743_B9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","unstructured":"9. Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903-75. doi: 10.1183\/13993003.01032-2015.","journal-title":"Eur Respir J"},{"issue":"13","key":"key20211008092743_B10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of Borderline Pulmonary Hypertension with Mortality and Hospitalization in a Large Patient Cohort: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program","volume":"133","author":"Maron","year":"2016","unstructured":"10. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, et al. Association of Borderline Pulmonary Hypertension with Mortality and Hospitalization in a Large Patient Cohort: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016;133(13):1240-8. doi: 10.1161\/CIRCULATIONAHA.115.020207.","journal-title":"Circulation"},{"issue":"6","key":"key20211008092743_B11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S1806-37132014000600004","article-title":"Left Ventricular Dysfunction in Patients with Suspected Pulmonary Arterial Hypertension","volume":"40","author":"Gavilanes","year":"2014","unstructured":"11. Gavilanes F, Alves JL Jr, Fernandes C, Prada LFL, Jardim CV, Morinaga LT, et al. Left Ventricular Dysfunction in Patients with Suspected Pulmonary Arterial Hypertension. J Bras Pneumol. 2014;40(6):609-16. doi: 10.1590\/S1806-37132014000600004.","journal-title":"J Bras Pneumol"},{"issue":"9","key":"key20211008092743_B12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary Vascular Resistance and Clinical Outcomes in Patients with Pulmonary Hypertension: A Retrospective Cohort Study","volume":"8","author":"Maron","year":"2020","unstructured":"12. Maron BA, Brittain EL, Hess E, Waldo SW, Bar\u00f3n AE, Huang S, et al. Pulmonary Vascular Resistance and Clinical Outcomes in Patients with Pulmonary Hypertension: A Retrospective Cohort Study. Lancet Respir Med. 2020;8(9):873-84. doi: 10.1016\/S2213-2600(20)30317-9.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"key20211008092743_B13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic Definitions and Updated Clinical Classification of Pulmonary Hypertension","volume":"53","author":"Simonneau","year":"2019","unstructured":"13. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic Definitions and Updated Clinical Classification of Pulmonary Hypertension. Eur Respir J. 2019;53(1):1801913. doi: 10.1183\/13993003.01913-2018.","journal-title":"Eur Respir J"},{"issue":"3","key":"key20211008092743_B14","first-page":"419","article-title":"Pulmonary Hypertension in General Cardiology Practice","volume":"113","author":"Calderaro","year":"2019","unstructured":"14. Calderaro D, Alves JL Jr, Fernandes CJCDS, Souza R. Pulmonary Hypertension in General Cardiology Practice. Arq Bras Cardiol. 2019;113(3):419-28. doi: 10.5935\/abc.20190188.","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"key20211008092743_B15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary Hypertension in Chronic Lung Disease and Hypoxia","volume":"53","author":"Nathan","year":"2019","unstructured":"15. Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, et al. Pulmonary Hypertension in Chronic Lung Disease and Hypoxia. Eur Respir J. 2019;53(1):1801914. doi: 10.1183\/13993003.01914-2018.","journal-title":"Eur Respir J"},{"issue":"4","key":"key20211008092743_B16","article-title":"Brazilian Thoracic Society Recommendations for the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension","volume":"46","author":"Fernandes","year":"2020","unstructured":"16. Fernandes CJCS, Ota-Arakaki JS, Campos FTAF, Corr\u00eaa RA, Gazzana MB, Jardim CVP, et al. Brazilian Thoracic Society Recommendations for the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension. J Bras Pneumol. 2020;46(4): e20200204. doi: 10.36416\/1806-3756\/e20200204.","journal-title":"J Bras Pneumol"},{"issue":"1","key":"key20211008092743_B17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01904-2018","article-title":"Diagnosis of Pulmonary Hypertension","volume":"53","author":"Frost","year":"2019","unstructured":"17. Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of Pulmonary Hypertension. Eur Respir J. 2019;53(1):1801904. doi: 10.1183\/13993003.01904-2018.","journal-title":"Eur Respir J"},{"issue":"4","key":"key20211008092743_B18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00141211","article-title":"Pregnancy Outcomes in Pulmonary Arterial Hypertension in the Modern Management Era","volume":"40","author":"Ja\u00efs","year":"2012","unstructured":"18. Ja\u00efs X, Olsson KM, Barbera JA, Blanco I, Torbicki A, Peacock A, et al. Pregnancy Outcomes in Pulmonary Arterial Hypertension in the Modern Management Era. Eur Respir J. 2012;40(4):881-5. doi: 10.1183\/09031936.00141211.","journal-title":"Eur Respir J"},{"issue":"130","key":"key20211008092743_B19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1183\/09059180.00005713","article-title":"Understanding the Impact of Pulmonary Arterial Hypertension on Patients\u2019 and Carers\u2019 Lives","volume":"22","author":"Guillevin","year":"2013","unstructured":"19. Guillevin L, Armstrong I, Aldrighetti R, Howard LS, Ryftenius H, Fischer A, et al. Understanding the Impact of Pulmonary Arterial Hypertension on Patients\u2019 and Carers\u2019 Lives. Eur Respir Rev. 2013;22(130):535-42. doi: 10.1183\/09059180.00005713.","journal-title":"Eur Respir Rev"},{"issue":"14","key":"key20211008092743_B20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.106.618397","article-title":"Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients with Severe Chronic Pulmonary Hypertension","volume":"114","author":"Mereles","year":"2006","unstructured":"20. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, et al. Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients with Severe Chronic Pulmonary Hypertension. Circulation. 2006;114(14):1482-9. doi: 10.1161\/CIRCULATIONAHA.106.618397.","journal-title":"Circulation"},{"issue":"4","key":"key20211008092743_B21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary Pulmonary Hypertension: Natural History and the Importance of Thrombosis","volume":"70","author":"Fuster","year":"1984","unstructured":"21. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary Pulmonary Hypertension: Natural History and the Importance of Thrombosis. Circulation. 1984;70(4):580-7. doi: 10.1161\/01.cir.70.4.580.","journal-title":"Circulation"},{"issue":"1","key":"key20211008092743_B22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","unstructured":"22. Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, et al. Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation. 2014;129(1):57-65. doi: 10.1161\/CIRCULATIONAHA.113.004526.","journal-title":"Circulation"},{"issue":"1","key":"key20211008092743_B23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and Medical Therapy of Pulmonary Arterial Hypertension","volume":"53","author":"Gali\u00e8","year":"2019","unstructured":"23. Gali\u00e8 N, Channick RN, Frantz RP, Gr\u00fcnig E, Jing ZC, Moiseeva O, et al. Risk stratification and Medical Therapy of Pulmonary Arterial Hypertension. Eur Respir J. 2019;53(1):1801889. doi: 10.1183\/13993003.01889-2018.","journal-title":"Eur Respir J"},{"issue":"2","key":"key20211008092743_B24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7326\/M14-1402","article-title":"Acute Vasodilator Responsiveness and Microvascular Recruitment in Idiopathic Pulmonary Arterial Hypertension","volume":"162","author":"Langleben","year":"2015","unstructured":"24. Langleben D, Orfanos SE, Giovinazzo M, Schlesinger RD, Hirsch AM, Blenkhorn F, et al. Acute Vasodilator Responsiveness and Microvascular Recruitment in Idiopathic Pulmonary Arterial Hypertension. Ann Intern Med. 2015;162(2):154-6. doi: 10.7326\/M14-1402.","journal-title":"Ann Intern Med"},{"issue":"2","key":"key20211008092743_B25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension","volume":"327","author":"Rich","year":"1992","unstructured":"25. Rich S, Kaufmann E, Levy PS. The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension. N Engl J Med. 1992;327(2):76-81. doi: 10.1056\/NEJM199207093270203.","journal-title":"N Engl J Med"},{"issue":"23","key":"key20211008092743_B26","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension","volume":"111","author":"Sitbon","year":"2005","unstructured":"26. Sitbon O, Humbert M, Ja\u00efs X, Ioos V, Hamid AM, Provencher S, et al. Long-term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension. Circulation. 2005;111(23):3105-11. doi: 10.1161\/CIRCULATIONAHA.104.488486.","journal-title":"Circulation"},{"issue":"3","key":"key20211008092743_B27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern Age Pathology of Pulmonary Arterial Hypertension","volume":"186","author":"Stacher","year":"2012","unstructured":"27. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, et al. Modern Age Pathology of Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2012;186(3):261-72. doi: 10.1164\/rccm.201201-0164OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"key20211008092743_B28","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of Pulmonary Arterial Hypertension","volume":"351","author":"Humbert","year":"2004","unstructured":"28. Humbert M, Sitbon O, Simonneau G. Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2004;351(14): 1425-36. doi: 10.1056\/NEJMra040291.","journal-title":"N Engl J Med"},{"issue":"4","key":"key20211008092743_B29","first-page":"382","article-title":"Role of Prostacyclin in Pulmonary Hypertension","volume":"2014","author":"Mitchell","year":"2014","unstructured":"29. Mitchell JA, Ahmetaj-Shala B, Kirkby NS, Wright WR, Mackenzie LS, Reed DM, et al. Role of Prostacyclin in Pulmonary Hypertension. Glob Cardiol Sci Pract. 2014;2014(4):382-93. doi: 10.5339\/gcsp.2014.53.","journal-title":"Glob Cardiol Sci Pract"},{"issue":"6","key":"key20211008092743_B30","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin Synthase Expression is Decreased in Lungs from Patients with Severe Pulmonary Hypertension","volume":"159","author":"Tuder","year":"1999","unstructured":"30. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, et al. Prostacyclin Synthase Expression is Decreased in Lungs from Patients with Severe Pulmonary Hypertension. Am J Respir Crit Care Med. 1999;159(6):1925-32. doi: 10.1164\/ajrccm.159.6.9804054.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"key20211008092743_B31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An Imbalance Between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension","volume":"327","author":"Christman","year":"1992","unstructured":"31. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, et al. An Imbalance Between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension. N Engl J Med. 1992;327(2):70-5. doi: 10.1056\/NEJM199207093270202.","journal-title":"N Engl J Med"},{"issue":"5","key":"key20211008092743_B32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A Comparison of Continuous Intravenous Epoprostenol (prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension","volume":"334","author":"Barst","year":"1996","unstructured":"32. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A Comparison of Continuous Intravenous Epoprostenol (prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension. N Engl J Med. 1996;334(5):296-301. doi: 10.1056\/NEJM199602013340504.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20211008092743_B33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03256644","article-title":"Prostanoids for Pulmonary Arterial Hypertension","volume":"2","author":"Gali\u00e8","year":"2003","unstructured":"33. Gali\u00e8 N, Manes A, Branzi A. Prostanoids for Pulmonary Arterial Hypertension. Am J Respir Med. 2003;2(2):123-37. doi: 10.1007\/BF03256644.","journal-title":"Am J Respir Med"},{"issue":"5","key":"key20211008092743_B34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled Iloprost for Severe Pulmonary Hypertension","volume":"347","author":"Olschewski","year":"2002","unstructured":"34. Olschewski H, Simonneau G, Gali\u00e8 N, Higenbottam T, Naeije R, Rubin LJ, et al. Inhaled Iloprost for Severe Pulmonary Hypertension. N Engl J Med. 2002;347(5):322-9. doi: 10.1056\/NEJMoa020204.","journal-title":"N Engl J Med"},{"issue":"26","key":"key20211008092743_B35","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the Treatment of Pulmonary Arterial Hypertension","volume":"373","author":"Sitbon","year":"2015","unstructured":"35. Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Gali\u00e8 N, et al. Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2015;373(26):2522-33. doi: 10.1056\/NEJMoa1503184.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20211008092743_B36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00018-010-0518-0","article-title":"Endothelin","volume":"68","author":"Kawanabe","year":"2011","unstructured":"36. Kawanabe Y, Nauli SM. Endothelin. Cell Mol Life Sci. 2011;68(2):195-203. doi: 10.1007\/s00018-010-0518-0.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"key20211008092743_B37","first-page":"62","article-title":"The Role of Endothelin-1 in Pulmonary Arterial Hypertension","volume":"2014","author":"Chester","year":"2014","unstructured":"37. Chester AH, Yacoub MH. The Role of Endothelin-1 in Pulmonary Arterial Hypertension. Glob Cardiol Sci Pract. 2014;2014(2):62-78. doi: 10.5339\/gcsp.2014.29.","journal-title":"Glob Cardiol Sci Pract"},{"issue":"12","key":"key20211008092743_B38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan Therapy for Pulmonary Arterial Hypertension","volume":"346","author":"Rubin","year":"2002","unstructured":"38. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan Therapy for Pulmonary Arterial Hypertension. N Engl J Med. 2002;346(12):896-903. doi: 10.1056\/NEJMoa012212.","journal-title":"N Engl J Med"},{"issue":"9","key":"key20211008092743_B39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension","volume":"369","author":"Pulido","year":"2013","unstructured":"39. Pulido T, Adzerikho I, Channick RN, Delcroix M, Gali\u00e8 N, Ghofrani HA, et al. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. N Engl J Med. 2013;369(9):809-18. doi: 10.1056\/NEJMoa1213917.","journal-title":"N Engl J Med"},{"issue":"23","key":"key20211008092743_B40","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-blind, Placebo-controlled, Multicenter, Efficacy (ARIES) Study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","unstructured":"40. Gali\u00e8 N, Olschewski H, Oudiz RJ, Torres F, Frost A, Ghofrani HA, et al. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-blind, Placebo-controlled, Multicenter, Efficacy (ARIES) Study 1 and 2. Circulation. 2008;117(23):3010-9. doi: 10.1161\/CIRCULATIONAHA.107.742510.","journal-title":"Circulation"},{"issue":"2","key":"key20211008092743_B41","article-title":"Nitric Oxide and Pulmonary Arterial Hypertension","volume":"2017","author":"Chester","year":"2017","unstructured":"41. Chester AH, Yacoub MH, Moncada S. Nitric Oxide and Pulmonary Arterial Hypertension. Glob Cardiol Sci Pract. 2017;2017(2):14. doi: 10.21542\/gcsp.2017.14.","journal-title":"Glob Cardiol Sci Pract"},{"issue":"1","key":"key20211008092743_B42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4097\/kjae.2010.58.1.4","article-title":"Nitric Oxide and Pulmonary Hypertension","volume":"58","author":"Sim","year":"2010","unstructured":"42. Sim JY. Nitric Oxide and Pulmonary Hypertension. Korean J Anesthesiol. 2010;58(1):4-14. doi: 10.4097\/kjae.2010.58.1.4.","journal-title":"Korean J Anesthesiol"},{"issue":"20","key":"key20211008092743_B43","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension","volume":"353","author":"Gali\u00e8","year":"2005","unstructured":"43. Gali\u00e8 N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension. N Engl J Med. 2005;353(20):2148-57. doi: 10.1056\/NEJMoa050010.","journal-title":"N Engl J Med"},{"issue":"10","key":"key20211008092743_B44","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14656566.2020.1727446","article-title":"Treatment of Pulmonary Hypertension with Riociguat: A Review of Current Evidence and Future Perspectives","volume":"21","author":"Boutou","year":"2020","unstructured":"44. Boutou AK, Pitsiou G. Treatment of Pulmonary Hypertension with Riociguat: A Review of Current Evidence and Future Perspectives. Expert Opin Pharmacother. 2020;21(10):1145-55. doi: 10.1080\/14656566.2020.1727446.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"key20211008092743_B45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the Treatment of Pulmonary Arterial Hypertension","volume":"369","author":"Ghofrani","year":"2013","unstructured":"45. Ghofrani HA, Gali\u00e8 N, Grimminger F, Gr\u00fcnig E, Humbert M, Jing ZC, et al. Riociguat for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2013;369(4):330-40. doi: 10.1056\/NEJMoa1209655.","journal-title":"N Engl J Med"},{"issue":"4","key":"key20211008092743_B46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension","volume":"369","author":"Ghofrani","year":"2013","unstructured":"46. Ghofrani HA, D\u2019Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension. N Engl J Med. 2013;369(4):319-29. doi: 10.1056\/NEJMoa1209657.","journal-title":"N Engl J Med"},{"issue":"9","key":"key20211008092743_B47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension","volume":"373","author":"Gali\u00e8","year":"2015","unstructured":"47. Gali\u00e8 N, Barber\u00e0 JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med. 2015;373(9):834-44. doi: 10.1056\/NEJMoa1413687.","journal-title":"N Engl J Med"},{"issue":"4","key":"key20211008092743_B48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(16)00027-8","article-title":"Combination Therapy versus Monotherapy for Pulmonary Arterial Hypertension: A Meta-analysis","volume":"4","author":"Lajoie","year":"2016","unstructured":"48. Lajoie AC, Lauzi\u00e8re G, Lega JC, Lacasse Y, Martin S, Simard S, et al. Combination Therapy versus Monotherapy for Pulmonary Arterial Hypertension: A Meta-analysis. Lancet Respir Med. 2016;4(4):291-305. doi: 10.1016\/S2213-2600(16)00027-8.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"key20211008092743_B49","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension: A Pilot Study","volume":"43","author":"Sitbon","year":"2014","unstructured":"49. Sitbon O, Ja\u00efs X, Savale L, Cottin V, Bergot E, Macari EA, et al. Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension: A Pilot Study. Eur Respir J. 2014;43(6):1691-7. doi: 10.1183\/09031936.00116313.","journal-title":"Eur Respir J"},{"key":"key20211008092743_B50","article-title":"Efficacy and Safety of Initial Triple Oral Versus Initial Double Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension (PAH): Results of The Randomized Controlled Triton Study","volume":"201","author":"Chin","year":"2020","unstructured":"50. Chin KM, Sitbon O, Doelberg M, Gibbs JSSR, Hoeper MM, Martin N, et al. Efficacy and Safety of Initial Triple Oral Versus Initial Double Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension (PAH): Results of The Randomized Controlled Triton Study. Am J Respir Crit Care Med. 2020; 201:A2928. doi: 10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A2928.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"key20211008092743_B51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40256-017-0262-z","article-title":"Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study","volume":"18","author":"Coghlan","year":"2018","unstructured":"51. Coghlan JG, Channick R, Chin K, Di Scala L, Gali\u00e8 N, Ghofrani HA, et al. Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study. Am J Cardiovasc Drugs. 2018;18(1):37-47. doi: 10.1007\/s40256-017-0262-z.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"3","key":"key20211008092743_B52","article-title":"Challenging the Concept of Adding More Drugs in Pulmonary Arterial Hypertension","volume":"50","author":"Fernandes","year":"2017","unstructured":"52. Fernandes CJCS, Humbert M, Souza R. Challenging the Concept of Adding More Drugs in Pulmonary Arterial Hypertension. Eur Respir J. 2017;50(3):1701527. doi: 10.1183\/13993003.01527-2017.","journal-title":"Eur Respir J"},{"issue":"2","key":"key20211008092743_B53","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk Assessment, Prognosis and Guideline Implementation in Pulmonary Arterial Hypertension","volume":"50","author":"Boucly","year":"2017","unstructured":"53. Boucly A, Weatherald J, Savale L, Ja\u00efs X, Cottin V, Prevot G, et al. Risk Assessment, Prognosis and Guideline Implementation in Pulmonary Arterial Hypertension. Eur Respir J. 2017;50(2):1700889. doi: 10.1183\/13993003.00889-2017.","journal-title":"Eur Respir J"},{"issue":"2","key":"key20211008092743_B54","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in Pulmonary Arterial Hypertension: Prediction by the 2015 European Pulmonary Hypertension Guidelines Risk Stratification Model","volume":"50","author":"Hoeper","year":"2017","unstructured":"54. Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, et al. Mortality in Pulmonary Arterial Hypertension: Prediction by the 2015 European Pulmonary Hypertension Guidelines Risk Stratification Model. Eur Respir J. 2017;50(2):1700740. doi: 10.1183\/13993003.00740-2017.","journal-title":"Eur Respir J"},{"issue":"47","key":"key20211008092743_B55","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A Comprehensive Risk Stratification at Early Follow-up Determines Prognosis in Pulmonary Arterial Hypertension","volume":"39","author":"Kylhammar","year":"2018","unstructured":"55. Kylhammar D, Kjellstr\u00f6m B, Hjalmarsson C, Jansson K, Nisell M, S\u00f6derberg S, et al. A Comprehensive Risk Stratification at Early Follow-up Determines Prognosis in Pulmonary Arterial Hypertension. Eur Heart J. 2018;39(47):4175-81. doi: 10.1093\/eurheartj\/ehx257.","journal-title":"Eur Heart J"},{"issue":"2","key":"key20211008092743_B56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison with ESC\/ERS-Based Risk Assessment Strategies","volume":"156","author":"Benza","year":"2019","unstructured":"56. Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, et al. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison with ESC\/ERS-Based Risk Assessment Strategies. Chest. 2019;156(2):323-37. doi: 10.1016\/j.chest.2019.02.004.","journal-title":"Chest"},{"issue":"6","key":"key20211008092743_B57","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.healun.2018.02.005","article-title":"Prognostic Relevance of Appropriate Renal Function Evaluation in Pulmonary Arterial Hypertension","volume":"37","author":"Alves","year":"2018","unstructured":"57. Alves JL Jr, Souza R. Prognostic Relevance of Appropriate Renal Function Evaluation in Pulmonary Arterial Hypertension. J Heart Lung Transplant. 2018;37(6):692-3. doi: 10.1016\/j.healun.2018.02.005.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"key20211008092743_B58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1756-185X.13001","article-title":"Pulmonary Hypertension in Connective Tissue Diseases: An Update","volume":"20","author":"Aithala","year":"2017","unstructured":"58. Aithala R, Alex AG, Danda D. Pulmonary Hypertension in Connective Tissue Diseases: An Update. Int J Rheum Dis. 2017;20(1):5-24. doi: 10.1111\/1756-185X.13001.","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"key20211008092743_B59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.14-1036","article-title":"Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases","volume":"147","author":"Alves","year":"2015","unstructured":"59. Alves JL Jr, Gavilanes F, Jardim C, Fernandes CJCDS, Morinaga LTK, Dias B, et al. Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases. Chest. 2015;147(2):495-501. doi: 10.1378\/chest.14-1036.","journal-title":"Chest"},{"issue":"2","key":"key20211008092743_B60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary Arterial Hypertension: Baseline Characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","unstructured":"60. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary Arterial Hypertension: Baseline Characteristics from the REVEAL Registry. Chest. 2010;137(2):376-87. doi: 10.1378\/chest.09-1140.","journal-title":"Chest"},{"issue":"4","key":"key20211008092743_B61","article-title":"Survival of Connective Tissue Disease Associated Pulmonary Arterial Hypertension","volume":"36","author":"Assad","year":"2018","unstructured":"61. Assad APL, Oleas FG, Alves JL Jr, Fernandes CJCS, Sampaio-Barros PD, Souza R. Survival of Connective Tissue Disease Associated Pulmonary Arterial Hypertension. Clin Exp Rheumatol. 2018;36(4):186.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"key20211008092743_B62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Chinese Patients","volume":"44","author":"Hao","year":"2014","unstructured":"62. Hao YJ, Jiang X, Zhou W, Wang Y, Gao L, Wang Y, et al. Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in Chinese Patients. Eur Respir J. 2014;44(4):963-72. doi: 10.1183\/09031936.00182813.","journal-title":"Eur Respir J"},{"issue":"11","key":"key20211008092743_B63","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies","volume":"37","author":"Avouac","year":"2010","unstructured":"63. Avouac J, Air\u00f2 P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies. J Rheumatol. 2010;37(11):2290-8. doi: 10.3899\/jrheum.100245.","journal-title":"J Rheumatol"},{"issue":"3","key":"key20211008092743_B64","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.autrev.2012.07.010","article-title":"Pulmonary Hypertension in Systemic Lupus Erythematosus: Prevalence, Predictors and Diagnostic Strategy","volume":"12","author":"Ruiz-Irastorza","year":"2013","unstructured":"64. Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C. Pulmonary Hypertension in Systemic Lupus Erythematosus: Prevalence, Predictors and Diagnostic Strategy. Autoimmun Rev. 2013;12(3):410-5. doi: 10.1016\/j.autrev.2012.07.010.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"key20211008092743_B65","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0961203318788163","article-title":"Factors Associated With Development and Mortality of Pulmonary Hypertension in Systemic Lupus Erythematosus Patients","volume":"27","author":"Kim","year":"2018","unstructured":"65. Kim JS, Kim D, Joo YB, Won S, Lee J, Shin J, et al. Factors Associated With Development and Mortality of Pulmonary Hypertension in Systemic Lupus Erythematosus Patients. Lupus. 2018;27(11):1769-77. doi: 10.1177\/0961203318788163.","journal-title":"Lupus"},{"issue":"7","key":"key20211008092743_B66","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-Based Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The DETECT study","volume":"73","author":"Coghlan","year":"2014","unstructured":"66. Coghlan JG, Denton CP, Gr\u00fcnig E, Bonderman D, Distler O, Khanna D, et al. Evidence-Based Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The DETECT study. Ann Rheum Dis. 2014;73(7):1340-9. doi: 10.1136\/annrheumdis-2013-203301.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"key20211008092743_B67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41584-018-0062-0","article-title":"Major Lung Complications of Systemic Sclerosis","volume":"14","author":"Denton","year":"2018","unstructured":"67. Denton CP, Wells AU, Coghlan JG. Major Lung Complications of Systemic Sclerosis. Nat Rev Rheumatol. 2018;14(9):511-27. doi: 10.1038\/s41584-018-0062-0.","journal-title":"Nat Rev Rheumatol"},{"issue":"145","key":"key20211008092743_B68","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0056-2017","article-title":"Pulmonary Hypertension in Systemic Sclerosis: Different Phenotypes","volume":"26","author":"Launay","year":"2017","unstructured":"68. Launay D, Sobanski V, Hachulla E, Humbert M. Pulmonary Hypertension in Systemic Sclerosis: Different Phenotypes. Eur Respir Rev. 2017;26(145):170056. doi: 10.1183\/16000617.0056-2017.","journal-title":"Eur Respir Rev"},{"issue":"6","key":"key20211008092743_B69","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/BOR.0b013e32834b8975","article-title":"Systemic Sclerosis and the Heart: Current Diagnosis and Management","volume":"23","author":"Desai","year":"2011","unstructured":"69. Desai CS, Lee DC, Shah SJ. Systemic Sclerosis and the Heart: Current Diagnosis and Management. Curr Opin Rheumatol. 2011;23(6):545-54. doi: 10.1097\/BOR.0b013e32834b8975.","journal-title":"Curr Opin Rheumatol"},{"key":"key20211008092743_B70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/eurheartj\/suz204","article-title":"Screening Strategies for Pulmonary Arterial Hypertension","volume":"21","author":"Kiely","year":"2019","unstructured":"70. Kiely DG, Lawrie A, Humbert M. Screening Strategies for Pulmonary Arterial Hypertension. Eur Heart J Suppl. 2019;21(Suppl K):9-20. doi: 10.1093\/eurheartj\/suz204.","journal-title":"Eur Heart J Suppl"},{"issue":"1","key":"key20211008092743_B71","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0517-5","article-title":"A Comparison of the Predictive Accuracy of Three Screening Models for Pulmonary Arterial Hypertension in Systemic Sclerosis","volume":"17","author":"Hao","year":"2015","unstructured":"71. Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, et al. A Comparison of the Predictive Accuracy of Three Screening Models for Pulmonary Arterial Hypertension in Systemic Sclerosis. Arthritis Res Ther. 2015;17(1):7. doi: 10.1186\/s13075-015-0517-5.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"key20211008092743_B72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive Therapy in Lupus- and Mixed Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Retrospective Analysis of Twenty-three Cases","volume":"58","author":"Jais","year":"2008","unstructured":"72. Jais X, Launay D, Yaici A, Le Pavec J, Tch\u00e9rakian C, Sitbon O, et al. Immunosuppressive Therapy in Lupus- and Mixed Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Retrospective Analysis of Twenty-three Cases. Arthritis Rheum. 2008;58(2):521-31. doi: 10.1002\/art.23303.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"key20211008092743_B73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive Therapy in Connective Tissue diseases-Associated Pulmonary Arterial Hypertension","volume":"130","author":"Sanchez","year":"2006","unstructured":"73. Sanchez O, Sitbon O, Ja\u00efs X, Simonneau G, Humbert M. Immunosuppressive Therapy in Connective Tissue diseases-Associated Pulmonary Arterial Hypertension. Chest. 2006;130(1):182-9. doi: 10.1378\/chest.130.1.182.","journal-title":"Chest"},{"issue":"2","key":"key20211008092743_B74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneurol.2011.1698","article-title":"Optimizing the Hachinski Ischemic Scale","volume":"69","author":"Hachinski","year":"2012","unstructured":"74. Hachinski V, Oveisgharan S, Romney AK, Shankle WR. Optimizing the Hachinski Ischemic Scale. Arch Neurol. 2012;69(2):169-75. doi: 10.1001\/archneurol.2011.1698.","journal-title":"Arch Neurol"},{"issue":"5","key":"key20211008092743_B75","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","article-title":"Primary Pulmonary Hypertension in HIV Infection","volume":"100","author":"Speich","year":"1991","unstructured":"75. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary Pulmonary Hypertension in HIV Infection. Chest. 1991;100(5):1268-71. doi: 10.1378\/chest.100.5.1268.","journal-title":"Chest"},{"issue":"6","key":"key20211008092743_B76","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.CIR.89.6.2722","article-title":"Pulmonary Hypertension in Patients With Human Immunodeficiency Virus Infection. Comparison with Primary Pulmonary Hypertension","volume":"89","author":"Petitpretz","year":"1994","unstructured":"76. Petitpretz P, Brenot F, Azarian R, Parent F, Rain B, Herve P, et al. Pulmonary Hypertension in Patients With Human Immunodeficiency Virus Infection. Comparison with Primary Pulmonary Hypertension. Circulation. 1994;89(6):2722-7. doi: 10.1161\/01.cir.89.6.2722.","journal-title":"Circulation"},{"issue":"1","key":"key20211008092743_B77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-Associated Pulmonary Arterial Hypertension: Survival and Prognostic Factors in the Modern Therapeutic Era","volume":"24","author":"Degano","year":"2010","unstructured":"77. Degano B, Guillaume M, Savale L, Montani D, Ja\u00efs X, Yaici A, et al. HIV-Associated Pulmonary Arterial Hypertension: Survival and Prognostic Factors in the Modern Therapeutic Era. AIDS. 2010;24(1):67-75. doi: 10.1097\/QAD.0b013e328331c65e.","journal-title":"AIDS"},{"issue":"6","key":"key20211008092743_B78","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/COH.0000000000000418","article-title":"HIV-associated Pulmonary Hypertension","volume":"12","author":"Jarrett","year":"2017","unstructured":"78. Jarrett H, Barnett C. HIV-associated Pulmonary Hypertension. Curr Opin HIV AIDS. 2017;12(6):566-71. doi: 10.1097\/COH.0000000000000418.","journal-title":"Curr Opin HIV AIDS"},{"key":"key20211008092743_B79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2459\/JCM.0b013e3283388fb3","article-title":"Efficacy of Sildenafil in HIV-Related Pulmonary Arterial Hypertension","volume":"16","author":"Pergola","year":"2015","unstructured":"79. Pergola V, Caruso C, Gnarini R, Fazio S, Ferraro S. Efficacy of Sildenafil in HIV-Related Pulmonary Arterial Hypertension. J Cardiovasc Med. 2015;16(Suppl 2):136-7. doi: 10.2459\/JCM.0b013e3283388fb3.","journal-title":"J Cardiovasc Med"},{"issue":"2","key":"key20211008092743_B80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2125.2000.00245.x","article-title":"Pharmacokinetic Interactions Between Sildenafil and Saquinavir\/Ritonavir","volume":"50","author":"Muirhead","year":"2000","unstructured":"80. Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N. Pharmacokinetic Interactions Between Sildenafil and Saquinavir\/Ritonavir. Br J Clin Pharmacol. 2000;50(2):99-107. doi: 10.1046\/j.1365-2125.2000.00245.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"key20211008092743_B81","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019848644","article-title":"Pharmacokinetic Interaction of Riociguat and Antiretroviral Combination Regimens in HIV-1-Infected Adults","volume":"9","author":"DeJesus","year":"2019","unstructured":"81. DeJesus E, Saleh S, Cheng S, van der Mey D, Becker C, Frey R, et al. Pharmacokinetic Interaction of Riociguat and Antiretroviral Combination Regimens in HIV-1-Infected Adults. Pulm Circ. 2019;9(2):2045894019848644. doi: 10.1177\/2045894019848644.","journal-title":"Pulm Circ"},{"issue":"1","key":"key20211008092743_B82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term Effects of Bosentan in Patients with HIV-Associated Pulmonary Arterial Hypertension","volume":"33","author":"Degano","year":"2009","unstructured":"82. Degano B, Ya\u00efci A, Le Pavec J, Savale L, Ja\u00efs X, Camara B, et al. Long-term Effects of Bosentan in Patients with HIV-Associated Pulmonary Arterial Hypertension. Eur Respir J. 2009;33(1):92-8. doi: 10.1183\/09031936.00094808.","journal-title":"Eur Respir J"},{"issue":"5","key":"key20211008092743_B83","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (Prostacyclin) Therapy in HIV-Associated Pulmonary Hypertension","volume":"162","author":"Aguilar","year":"2000","unstructured":"83. Aguilar RV, Farber HW. Epoprostenol (Prostacyclin) Therapy in HIV-Associated Pulmonary Hypertension. Am J Respir Crit Care Med. 2000;162(5):1846-50. doi: 10.1164\/ajrccm.162.5.2004042.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"key20211008092743_B84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/17512433.2016.1151785","article-title":"Pharmacological Treatment of HIV-Associated Pulmonary Hypertension","volume":"9","author":"Chinello","year":"2016","unstructured":"84. Chinello P, Petrosillo N. Pharmacological Treatment of HIV-Associated Pulmonary Hypertension. Expert Rev Clin Pharmacol. 2016;9(5):715-25. doi: 10.1586\/17512433.2016.1151785.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"key20211008092743_B85","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/bcp.12650","article-title":"Effect of Lopinavir\/Ritonavir on the Pharmacokinetics of Selexipag an Oral Prostacyclin Receptor Agonist and its Active Metabolite in Healthy Subjects","volume":"80","author":"Kaufmann","year":"2015","unstructured":"85. Kaufmann P, Niglis S, Bruderer S, Segrestaa J, \u00c4\u00e4nismaa P, Halabi A, et al. Effect of Lopinavir\/Ritonavir on the Pharmacokinetics of Selexipag an Oral Prostacyclin Receptor Agonist and its Active Metabolite in Healthy Subjects. Br J Clin Pharmacol. 2015;80(4):670-7. doi: 10.1111\/bcp.12650.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"key20211008092743_B86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1665-2681(19)31832-0","article-title":"Portopulmonary Hypertension: State of the Art","volume":"7","author":"Porres-Aguilar","year":"2008","unstructured":"86. Porres-Aguilar M, Zuckerman MJ, Figueroa-Casas JB, Krowka MJ. Portopulmonary Hypertension: State of the Art. Ann Hepatol. 2008;7(4):321-30. doi: 10.1016\/S1665-2681(19)31832-0","journal-title":"Ann Hepatol"},{"issue":"2","key":"key20211008092743_B87","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.14-1036","article-title":"Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases","volume":"147","author":"Alves","year":"2015","unstructured":"87. Alves JL Jr, Gavilanes F, Jardim C, Fernandes CJCDS, Morinaga LTK, Dias B, et al. Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases. Chest. 2015;147(2):495-501. doi: 10.1378\/chest.14-1036. (Cita\u00e7\u00e3o repetida (vide n\u00ba 59). Verificar com os autores a possibilidade de incluir outra cita\u00e7\u00e3o no lugar da 87 ou se ser\u00e1 preciso renumerar todas as cita\u00e7\u00f5es a partir deste ponto.)","journal-title":"Chest"},{"issue":"5","key":"key20211008092743_B88","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/lt.500030503","article-title":"Severe Pulmonary Hypertension in Liver Transplant Candidates","volume":"3","author":"Ramsay","year":"1997","unstructured":"88. Ramsay MA, Simpson BR, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe Pulmonary Hypertension in Liver Transplant Candidates. Liver Transpl Surg. 1997;3(5):494-500. doi: 10.1002\/lt.500030503.","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"key20211008092743_B89","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary Hypertension: Survival and Prognostic Factors","volume":"178","author":"Le Pavec","year":"2008","unstructured":"89. Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med. 2008;178(6):637-43. doi: 10.1164\/rccm.200804-613OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"key20211008092743_B90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1378\/chest.09-2816","article-title":"Worldwide Physician Education and Training in Pulmonary Hypertension: Pulmonary Vascular Disease: The Global Perspective","volume":"137","author":"Elliott","year":"2010","unstructured":"90. Elliott CG, Barst RJ, Seeger W, Porres-Aguilar M, Brown LM, Zamanian RT, et al. Worldwide Physician Education and Training in Pulmonary Hypertension: Pulmonary Vascular Disease: The Global Perspective. Chest. 2010;137(Suppl 6):85-94. doi: 10.1378\/chest.09-2816.","journal-title":"Chest"},{"issue":"2","key":"key20211008092743_B91","first-page":"113","article-title":"Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature","volume":"14","author":"Cosarderelioglu","year":"2016","unstructured":"91. Cosarderelioglu C, Cosar AM, Gurakar M, Pustavoitau A, Russell SD, Dagher NN, et al. Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. Exp Clin Transplant. 2016;14(2):113-20. doi: 10.6002\/ect.2015.0351.","journal-title":"Exp Clin Transplant"},{"issue":"6","key":"key20211008092743_B92","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with Inhaled Iloprost and Bosentan in Portopulmonary Hypertension","volume":"30","author":"Hoeper","year":"2007","unstructured":"92. Hoeper MM, Seyfarth HJ, Hoeffken G, Wirtz H, Spiekerkoetter E, Pletz MW, et al. Experience with Inhaled Iloprost and Bosentan in Portopulmonary Hypertension. Eur Respir J. 2007;30(6):1096-102. doi: 10.1183\/09031936.00032407.","journal-title":"Eur Respir J"},{"issue":"5","key":"key20211008092743_B93","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/hep.31166","article-title":"PORTICO: First Randomized Controlled Trial of Vasomodulator Therapy in Portopulmonary Hypertension","volume":"71","author":"Raevens","year":"2020","unstructured":"93. Raevens S, Fallon MB. PORTICO: First Randomized Controlled Trial of Vasomodulator Therapy in Portopulmonary Hypertension. Hepatology. 2020;71(5):1870-2. doi: 10.1002\/hep.31166.","journal-title":"Hepatology"},{"issue":"1","key":"key20211008092743_B94","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious Effects of Beta-blockers on Exercise Capacity and Hemodynamics in Patients with Portopulmonary Hypertension","volume":"130","author":"Provencher","year":"2006","unstructured":"94. Provencher S, Herve P, Jais X, Lebrec D, Humbert M, Simonneau G, et al. Deleterious Effects of Beta-blockers on Exercise Capacity and Hemodynamics in Patients with Portopulmonary Hypertension. Gastroenterology. 2006;130(1):120-6. doi: 10.1053\/j.gastro.2005.10.013.","journal-title":"Gastroenterology"},{"issue":"6","key":"key20211008092743_B95","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary Hypertension: Results From a 10-year Screening Algorithm","volume":"44","author":"Krowka","year":"2006","unstructured":"95. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary Hypertension: Results From a 10-year Screening Algorithm. Hepatology. 2006;44(6):1502-10. doi: 10.1002\/hep.21431.","journal-title":"Hepatology"},{"issue":"5","key":"key20211008092743_B96","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MCP.0000000000000300","article-title":"Pulmonary Arterial Hypertension in Schistosomiasis","volume":"22","author":"Gavilanes","year":"2016","unstructured":"96. Gavilanes F, Fernandes CJ, Souza R. Pulmonary Arterial Hypertension in Schistosomiasis. Curr Opin Pulm Med. 2016;22(5):408-14. doi: 10.1097\/MCP.0000000000000300.","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"key20211008092743_B97","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00307-2018","article-title":"Survival of Patients with Schistosomiasis-Associated Pulmonary Arterial Hypertension in the Modern Management Era","volume":"51","author":"Fernandes","year":"2018","unstructured":"97. Fernandes CJC, Piloto B, Castro M, Oleas FG, Alves JL Jr, Prada LFL, et al. Survival of Patients with Schistosomiasis-Associated Pulmonary Arterial Hypertension in the Modern Management Era. Eur Respir J. 2018;51(6):1800307. doi: 10.1183\/13993003.00307-2018.","journal-title":"Eur Respir J"},{"issue":"5","key":"key20211008092743_B98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1586\/ers.11.58","article-title":"Schistosomiasis and Pulmonary Hypertension","volume":"5","author":"Fernandes","year":"2011","unstructured":"98. Fernandes CJ, Jardim CV, Hovnanian A, Hoette S, Morinaga LK, Souza R. Schistosomiasis and Pulmonary Hypertension. Expert Rev Respir Med. 2011;5(5):675-81. doi: 10.1586\/ers.11.58.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"key20211008092743_B99","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1378\/chest.11-0483","article-title":"The Role of Target Therapies in Schistosomiasis-Associated Pulmonary Arterial Hypertension","volume":"141","author":"Fernandes","year":"2012","unstructured":"99. Fernandes CJCS, Dias BA, Jardim CVP, Hovnanian A, Hoette S, Morinaga LK, et al. The Role of Target Therapies in Schistosomiasis-Associated Pulmonary Arterial Hypertension. Chest. 2012;141(4):923-8. doi: 10.1378\/chest.11-0483.","journal-title":"Chest"},{"key":"key20211008092743_B100","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-015-0115-y","article-title":"Pulmonary Artery Enlargement in Schistosomiasis Associated Pulmonary Arterial Hypertension","volume":"15","author":"Hoette","year":"2015","unstructured":"100. Hoette S, Figueiredo C, Dias B, Alves JL Jr, Gavilanes F, Prada LFL, et al. Pulmonary Artery Enlargement in Schistosomiasis Associated Pulmonary Arterial Hypertension. BMC Pulm Med. 2015;15:118. doi: 10.1186\/s12890-015-0115-y.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"key20211008092743_B101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCP.0000000000000603","article-title":"The Global View","volume":"25","author":"Fernandes","year":"2019","unstructured":"101. Fernandes CJC, Jardim C, Souza R. The Global View. Curr Opin Pulm Med. 2019;25(5):391-7. doi: 10.1097\/MCP.0000000000000603.","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"key20211008092743_B102","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary Arterial Hypertension in Adults Born with a Heart Septal Defect: The Euro Heart Survey on Adult Congenital Heart Disease","volume":"93","author":"Engelfriet","year":"2007","unstructured":"102. Engelfriet PM, Duffels MG, M\u00f6ller T, Boersma E, Tijssen JG, Thaulow E, et al. Pulmonary Arterial Hypertension in Adults Born with a Heart Septal Defect: The Euro Heart Survey on Adult Congenital Heart Disease. Heart. 2007;93(6):682-7. doi: 10.1136\/hrt.2006.098848.","journal-title":"Heart"},{"issue":"9","key":"key20211008092743_B103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacc.2008.11.025","article-title":"Eisenmenger Syndrome a Clinical Perspective in a New Therapeutic Era of Pulmonary Arterial Hypertension","volume":"53","author":"Beghetti","year":"2009","unstructured":"103. Beghetti M, Gali\u00e8 N. Eisenmenger Syndrome a Clinical Perspective in a New Therapeutic Era of Pulmonary Arterial Hypertension. J Am Coll Cardiol. 2009;53(9):733-40. doi: 10.1016\/j.jacc.2008.11.025.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"key20211008092743_B104","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.04.056","article-title":"Pulmonary Arterial Thrombosis in Eisenmenger Syndrome is Associated with Biventricular Dysfunction and Decreased Pulmonary flow Velocity","volume":"50","author":"Broberg","year":"2007","unstructured":"104. Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, et al. Pulmonary Arterial Thrombosis in Eisenmenger Syndrome is Associated with Biventricular Dysfunction and Decreased Pulmonary flow Velocity. J Am Coll Cardiol. 2007;50(7):634-42. doi: 10.1016\/j.jacc.2007.04.056.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20211008092743_B105","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1164\/ajrccm.164.9.2106076","article-title":"Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome","volume":"164","author":"Sandoval","year":"2001","unstructured":"105. Sandoval J, Aguirre JS, Pulido T, Martinez-Guerra ML, Santos E, Alvarado P, et al. Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome. Am J Respir Crit Care Med. 2001;164(9):1682-7. doi: 10.1164\/ajrccm.164.9.2106076.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"key20211008092743_B106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan Therapy in Patients with Eisenmenger Syndrome: A Multicenter, Double-blind, Randomized, Placebo-controlled Study","volume":"114","author":"Gali\u00e8","year":"2006","unstructured":"106. Gali\u00e8 N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, et al. Bosentan Therapy in Patients with Eisenmenger Syndrome: A Multicenter, Double-blind, Randomized, Placebo-controlled Study. Circulation. 2006;114(1):48-54. doi: 10.1161\/CIRCULATIONAHA.106.630715.","journal-title":"Circulation"},{"issue":"1","key":"key20211008092743_B107","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric Pulmonary Arterial hypertension: Updates on Definition, Classification, Diagnostics and Management","volume":"53","author":"Rosenzweig","year":"2019","unstructured":"107. Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, et al. Paediatric Pulmonary Arterial hypertension: Updates on Definition, Classification, Diagnostics and Management. Eur Respir J. 2019;53(1):1801916. doi: 10.1183\/13993003.01916-2018.","journal-title":"Eur Respir J"},{"issue":"5","key":"key20211008092743_B108","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-0033-1355438","article-title":"Birth Control and Pregnancy Management in Pulmonary Hypertension","volume":"34","author":"Olsson","year":"2013","unstructured":"108. Olsson KM, Jais X. Birth Control and Pregnancy Management in Pulmonary Hypertension. Semin Respir Crit Care Med. 2013;34(5):681-8. doi: 10.1055\/s-0033-1355438.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"key20211008092743_B109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/682230","article-title":"Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute","volume":"5","author":"Hemnes","year":"2015","unstructured":"109. Hemnes AR, Kiely DG, Cockrill BA, Safdar Z, Wilson VJ, Al Hazmi M, et al. Statement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2015;5(3):435-65. doi: 10.1086\/682230.","journal-title":"Pulm Circ"},{"issue":"2","key":"key20211008092743_B110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1783\/147118906776276486","article-title":"Pregnancy and Contraception in Heart Disease and Pulmonary Arterial Hypertension","volume":"32","author":"Thorne","year":"2006","unstructured":"110. Thorne S, Nelson-Piercy C, MacGregor A, Gibbs S, Crowhurst J, Panay N, et al. Pregnancy and Contraception in Heart Disease and Pulmonary Arterial Hypertension. J Fam Plann Reprod Health Care. 2006;32(2):75-81. doi: 10.1783\/147118906776276486.","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"142","key":"key20211008092743_B111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1183\/16000617.0079-2016","article-title":"Pregnancy in pulmonary arterial hypertension","volume":"25","author":"Olsson","year":"2016","unstructured":"111. Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016;25(142): 431-7. doi: 10.1183\/16000617.0079-2016","journal-title":"Eur Respir Rev"},{"issue":"9","key":"key20211008092743_B112","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ejhf.594","article-title":"Pulmonary Hypertension and Pregnancy Outcomes: Data From the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology","volume":"18","author":"Sliwa","year":"2016","unstructured":"112. Sliwa K, van Hagen IM, Budts W, Swan L, Sinagra G, Caruana M, et al. Pulmonary Hypertension and Pregnancy Outcomes: Data From the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016;18(9):1119-28. doi: 10.1002\/ejhf.594.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"key20211008092743_B113","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1378\/chest.12-0528","article-title":"Management of Pulmonary Arterial Hypertension During Pregnancy: A Retrospective, Multicenter Experience","volume":"143","author":"Duarte","year":"2013","unstructured":"113. Duarte AG, Thomas S, Safdar Z, Torres F, Pacheco LD, Feldman J, et al. Management of Pulmonary Arterial Hypertension During Pregnancy: A Retrospective, Multicenter Experience. Chest. 2013;143(5):1330-1336. doi: 10.1378\/chest.12-0528.","journal-title":"Chest"},{"issue":"10","key":"key20211008092743_B114","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006144","article-title":"Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample","volume":"6","author":"Thomas","year":"2017","unstructured":"114. Thomas E, Yang J, Xu J, Lima FV, Stergiopoulos K. Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample. J Am Heart Assoc. 2017;6(10):e006144. doi: 10.1161\/JAHA.117.006144.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"key20211008092743_B115","first-page":"73","article-title":"Pulmonary Arterial Hypertension and Pregnancy","volume":"18","author":"Terek","year":"2013","unstructured":"115. Terek D, Kayikcioglu M, Kultursay H, Ergenoglu M, Yalaz M, Musayev O, et al. Pulmonary Arterial Hypertension and Pregnancy. J Res Med Sci. 2013;18(1):73-6.","journal-title":"J Res Med Sci"},{"issue":"2","key":"key20211008092743_B116","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijoa.2008.10.006","article-title":"Pulmonary hypertension and pregnancy","volume":"18","author":"Madden","year":"2009","unstructured":"116. Madden BP. Pulmonary hypertension and pregnancy. Int J Obstet Anesth. 2009;18(2):156-64. doi: 10.1016\/j.ijoa.2008.10.006.","journal-title":"Int J Obstet Anesth"},{"issue":"23","key":"key20211008092743_B117","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.jacc.2017.03.597","article-title":"Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina","volume":"69","author":"Gali\u00e8","year":"2017","unstructured":"117. Gali\u00e8 N, Saia F, Palazzini M, Manes A, Russo V, Reggiani MLB, et al. Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina. J Am Coll Cardiol. 2017;69(23):2808-2817. doi: 10.1016\/j.jacc.2017.03.597.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20211008092743_B118","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1522-726X(200101)52:1<49::AID-CCD1012>3.0.CO;2-0","article-title":"Extrinsic Compression of the Left Main Coronary Artery by a Dilated Pulmonary Artery: Clinical, Angiographic, and Hemodynamic Determinants","volume":"52","author":"Kajita","year":"2001","unstructured":"118. Kajita LJ, Martinez EE, Ambrose JA, Lemos PA, Esteves A, Gama MN, et al. Extrinsic Compression of the Left Main Coronary Artery by a Dilated Pulmonary Artery: Clinical, Angiographic, and Hemodynamic Determinants. Catheter Cardiovasc Interv. 2001;52(1):49-54. doi: 10.1002\/1522-726x(200101)52:1<49::aid-ccd1012>3.0.co;2-0.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"key20211008092743_B119","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.chest.2019.04.099","article-title":"Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension","volume":"156","author":"Fernandes","year":"2019","unstructured":"119. Fernandes CJ, Steigner ML, Piazza G, Goldhaber SZ. Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension. Chest. 2019;156(2):200-202. doi: 10.1016\/j.chest.2019.04.099.","journal-title":"Chest"},{"issue":"3","key":"key20211008092743_B120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jcin.2018.08.002","article-title":"Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting","volume":"12","author":"Saia","year":"2019","unstructured":"120. Saia F, Dall\u2019Ara G, Marzocchi A, Dardi F, Palazzini M, Manes A, et al. Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting. JACC Cardiovasc Interv. 2019;12(3):319-21. doi: 10.1016\/j.jcin.2018.08.002.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"key20211008092743_B121","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","article-title":"Incidence and Clinical Relevance of Supraventricular Tachyarrhythmias in Pulmonary Hypertension","volume":"153","author":"Tongers","year":"2007","unstructured":"121. Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp JM, et al. Incidence and Clinical Relevance of Supraventricular Tachyarrhythmias in Pulmonary Hypertension. Am Heart J. 2007;153(1):127-32. doi: 10.1016\/j.ahj.2006.09.008.","journal-title":"Am Heart J"},{"issue":"23","key":"key20211008092743_B122","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1136\/heartjnl-2017-312881","article-title":"Arrhythmias in Adult Patients With Congenital Heart Disease and Pulmonary Arterial Hypertension","volume":"104","author":"Drakopoulou","year":"2018","unstructured":"122. Drakopoulou M, Nashat H, Kempny A, Alonso-Gonzalez R, Swan L, Wort SJ, et al. Arrhythmias in Adult Patients With Congenital Heart Disease and Pulmonary Arterial Hypertension. Heart. 2018;104(23):1963-69. doi: 10.1136\/heartjnl-2017-312881.","journal-title":"Heart"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/atualizacao-no-tratamento-da-hipertensao-arterial-pulmonar\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:06:37Z","timestamp":1747400797000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/atualizacao-no-tratamento-da-hipertensao-arterial-pulmonar\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10,7]]}},"alternative-id":["10.36660\/abc.20200702"],"URL":"https:\/\/doi.org\/10.36660\/abc.20200702","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}